Cambrex Corp. (CBM) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts CBM Hot Sheet
Join SI Premium – FREE
Cambrex Corp. (NYSE: CBM) reported Q2 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $67.5 million versus the consensus estimate of $62.1 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
